Abstract
Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by articular and extra-articular manifestations. Among extra-articular involvement, rheumatoid meningitis (RM) is a rare condition, which may exhibit variable symptoms including headache, focal and/or generalized neurologic deficits. It may develop as the preceding manifestation of RA or occur at any time of the disease course. Some drugs used for the treatment of RA may give rise to aseptic meningitis or create a tendency to infectious meningitis due to their immunosuppressive effect. All these possibilities may lead to difficulties in the differential diagnosis. Achieving a diagnosis in a short time is crucial in terms of prognosis. Here, we would like to report a case with longstanding RA manifested by left-sided weakness and seizure shortly after initiating etanercept (ETA) therapy. ETA-induced meningitis was confirmed with appropriate diagnostic tools. Our aim with this case-based review is to attract the attention of this rare condition and discuss diagnostic challenges.
Similar content being viewed by others
References
Sparks JA (2019) Rheumatoid arthritis. Ann Intern Med 170(1):ITC1–ITC16
Parsons AM, Aslam F, Grill MF, Aksamit AJ, Goodman BP (2020) Rheumatoid meningitis: clinical characteristics, diagnostic evaluation, and treatment. Neurohospitalist 10(2):88–94
Atzeni F, Talotta R, Masala IF, Gerardi MC, Casale R, Sarzi-Puttini P (2018) Central nervous system involvement in rheumatoid arthritis patients and the potential implications of using biological agents. Best Pract Res ClinRheumatol 32(4):500–510
Tsuzaki K, Nakamura T, Okumura H, Tachibana N, Hamano T (2017) Rheumatoid meningitis occurring during etanercept treatment. Case Rep Neurol Med. https://doi.org/10.1155/2017/7638539
Ahmed M, Luggen M, Herman JH, Weiss KL, Decourten-Myers G, Quinlan JG, Khanna D (2006) Hypertrophic pachymeningitis in rheumatoid arthritis after adalimumab administration. J Rheumatol 33(11):2344–2346
Seago S, Stroberg E, Metting A (2016) Rheumatoid meningitis associated with infliximab. Proc (BaylUniv Med Cent) 29(2):204–206
Durel CA, Feurer E, Pialat JB, Berthoux E, Chapurlat RD, Confavreux CB (2013) Etanercept may induce neurosarcoidosis in a patient treated for rheumatoid arthritis. BMC Neurol 28(13):212
Wright WF, Pinto CN, Palisoc K, Baghli S (2019) Viral (aseptic) meningitis: a review. J NeurolSci 398:176–183
Gasparyan AY, Ayvazyan L, Blackmore H, Kitas GD (2011) Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors. RheumatolInt 31:1409–1417
Gherghel N, Stan A, Stan H (2018) Pearls & Oy-sters: rheumatoid meningitis occurring during treatment with etanercept. Neurology 91(17):806–808
Koopmansch C, D’Haene N, Hastir D, Sadeghi N, Maris C, Salmon I (2016) A 63-year-old woman with a right frontal lesion. Brain Pathol 26(4):555–556
Huys AC, Guerne PA, Horvath J (2012) Rheumatoid meningitis occurring during adalimumab and methotrexate treatment. Joint Bone Spine 79(1):90–92
Chou RC, Henson JW, Tian D, Hedley-Whyte ET, Reginato AM (2006) Successful treatment of rheumatoid meningitis with cyclophosphamide but not infliximab. Ann Rheum Dis 65(8):1114–1116
Nihat A, Chinthapalli K, Bridges L, Johns P, Sofat N, Moynihan B (2016) Rheumatoid meningitis. PractNeurol 16(4):312–314
Qin Z, Kim J, Valencia D, Hamoodi L, Neltner J, Sizemore T, Lightfoot R Jr (2020) Rheumatoid meningitis: a case report and review of the literature. NeurolClinPract 10(1):73–83
Marotte H, Charrin JE, Miossec P (2001) Infliximab-induced aseptic meningitis. Lancet 358(9295):1784
Cavazzana I, Taraborelli M, Fredi M, Tincani A, Franceschini F (2014) Aseptic meningitis occurring during anti-TNF-alpha therapy in rheumatoid arthritis and ankylosing spondylitis. ClinExpRheumato 32(5):732–734 (Epub 2014 Sep 8)
Trabelsi M, Romand X, Gilson M, Vaillant M, Guerne PA, Hayem G, Bertolini E, Baillet A, Gaudin P (2020) Rheumatoid meningitis a rare extra-articular manifestation of rheumatoid arthritis: report of 6 cases and literature review. J Clin Med 9(6):1625
Jazeron A, Lallier JC, Rihn B, Thiercelin MC (2010) Aseptic meningitis possibly induced by adalimumab. Joint Bone Spine 77(6):618–619
Booker MJ, Flint J, Saravana S (2008) Aseptic meningitis in a patient taking etanercept for rheumatoid arthritis: a case report. Cases J 1(1):364
Figueroa Rodriguez F, Minkyung K, Jinna S, Farshad S, Davila F (2018) Rheumatoid meningoencephalitis: a feared condition in the era of tnf blockers. Case Rep Rheumatol 2018:4610260
Matsushima M, Yaguchi H, Niino M, Akimoto-Tsuji S, Yabe I, Onishi K, Sasaki H (2010) MRI and pathological findings of rheumatoid meningitis. J ClinNeurosci 17(1):129–132
Starosta MA, Brandwein SR (2007) Clinical manifestations and treatment of rheumatoid pachymeningitis. Neurology 68(13):1079–1080
Tortorella C, Prosperini L, Sebastiani G, Gasperini C (2020) Unilateral meningitis: unusual central nervous system involvement in rheumatoid arthritis. PractNeurol. https://doi.org/10.1136/practneurol-2020-002685
Inoue C, Hagiya H, Nishimura Y, Sui O (2020) Rheumatoid meningoencephalitis. Intern Med 59(24):3255–3256
Schmid L, Müller M, Treumann T, Arnold W, Möller B, Aeberli D, Villiger PM (2009) Induction of complete and sustained remission of rheumatoid pachymeningitis by rituximab. Arthritis Rheum 60(6):1632–1634
McKenna MC, Vaughan D, Bermingham N, Cronin S (2019) Rheumatoid arthritis presenting as rheumatoid meningitis. BMJ Case Rep 12(1):bcr-2018-226649
Finkelshtein V, Lampl Y, Lorberboym M, Kanner A, Ben-Ami Raichman D, Dabby R, Tanay A (2018) Self-limited rheumatoid meningitis as a presenting symptom of rheumatoid arthritis. Isr Med Assoc J 20(4):262–264
Li SY, Birnbaum AD, Goldstein DA (2010) Optic neuritis associated with adalimumab in the treatment of uveitis. OculImmunolInflamm 18(6):475–481
Seror R, Richez C, Sordet C, Rist S, Gossec L, Direz G, Houvenagel E, Berthelot JM, Pagnoux C, Dernis E, Melac-Ducamp S, Bouvard B, Asquier C, Martin A, Puechal X, Mariette X; Club Rhumatismes et Inflammation Section of the SFR (2013) Pattern of demyelination occurring during anti-TNF-α therapy: a French national survey. Rheumatology (Oxford) 52(5):868–874
Kunchok A, Aksamit AJ Jr, Davis JM 3rd, Kantarci OH, Keegan BM, Pittock SJ, Weinshenker BG, McKeon A (2020) association between tumor necrosis factor inhibitor exposure and inflammatory central nervous system events. JAMA Neurol 77(8):937–946
Yelehe-Okouma M, Czmil-Garon J, Pape E, Petitpain N, Gillet P (2018) Drug-induced aseptic meningitis: a mini-review. FundamClinPharmacol 32(3):252–260
Shapiro WR, Young DF (1984) Neurological complications of antineoplastic therapy. ActaNeurolScandSuppl 100:125–132
Hawboldt J, Bader M (2007) Intramuscular methotrexate-induced aseptic meningitis. Ann Pharmacother 41(11):1906–1911
Vieira WP, Nobre CA, Filho JD, Vieira RM, Callado MR (2009) Meningitetuberculosaduranteterapia com infliximab (Tuberculosis meningitis during infliximab therapy). ActaRheumatol Port 34(4):681–682
Parsons AM, Zuniga LA, Hoxworth JM, Lyons M, Aslam F, Goodman BP (2018) Rheumatoid meningitis: a case review. Neurologist 23(3):83–85
Kemanetzoglou E, Andreadou E (2017) CNS demyelination with TNF-α blockers. CurrNeurolNeurosci Rep 17(4):36
Robinson WH, Genovese MC, Moreland LW (2001) Demyelinating and neurologic events reported in association with tumor necrosis factor alpha antagonism: by what mechanisms could tumor necrosis factor alpha antagonists improve rheumatoid arthritis but exacerbate multiple sclerosis? Arthritis Rheum 44(9):1977–1983
Funding
No funding.
Author information
Authors and Affiliations
Contributions
Study concept and design: RY, DUC, and CK; analysis and interpretation of data: RY, DUC, DA, SS and CK; drafting of the manuscript: RY, DUC, DA, SS and CK, critically revision of the manuscript for important intellectual content: RY, DUC, and CK; final approval of the version to be published: RY, DUC, DA, SS and CK.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that there is no conflict of interest.
Ethical approval
All procedures performed in studies involving human participants were by the ethical standards of the institutional and/or national research committee and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.
Informed consent
Informed consent was obtained from our patient.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Yıldırım, R., Cansu, D.Ü., Arık, D. et al. Aseptic meningitis in rheumatoid arthritis after anti-TNF administration: a case-based literature review. Rheumatol Int 41, 1845–1853 (2021). https://doi.org/10.1007/s00296-021-04822-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-021-04822-6